FDA approves first flu drug in 20 years; Trump proposes global index to check drug price rise

This week, Phispers brings you news on US President Donald Trump’s new payment model, proposed ahead of the midterm polls, to closely align the cost of Medicare Part B drugs with the prices in other countries. The USFDA ap...

FDA approves first flu drug in 20 years; Trump proposes global index to check drug price rise

01 Nov 2018

Radio Compass

PharmaCompass.com

Top Pharma & Biotech Deals, Investments, M&As in September 2018

As compared to the previous months, September was a slower month for dealmaking. The Wall Street Journal recently attributed the drought in big biotech deals to the riskiness of the business. In a note to clients, a Jefferies he...

Top Pharma & Biotech Deals, Investments, M&As in September 2018

25 Oct 2018

Radio Compass

PharmaCompass.com

Recipharm’s UK facility fails GMP inspection; FDA proposes harmonization of standards for generic drugs

This week, Phispers brings you news on AstraZeneca’s Lynparza that has shown strong benefits for women with ovarian cancer. Novartis has expanded its radioligand therapeutic (RLT) pipeline of targeted oncology treatment by...

Recipharm’s UK facility fails GMP inspection; FDA proposes harmonization of standards for generic drugs

25 Oct 2018

Radio Compass

PharmaCompass.com

Aurobindo’s sartan banned in Europe; Dr. Reddy’s cost optimization drive continues, sells off another site

This week, Phispers brings you news from Dr. Reddy’s Laboratories in India which is divesting its API plant in Hyderabad in order to optimize its cost structure. J&J and Bayer’s blood thinner Xarelto was found to...

Aurobindo’s sartan banned in Europe; Dr. Reddy’s cost optimization drive continues, sells off another site

18 Oct 2018

Radio Compass

PharmaCompass.com

Cancer researchers bag Nobel Prize; Fresenius wins case over terminating merger with Akorn due to data-integrity issues

The big news from the world of pharmaceuticals this week came from two cancer researchers — James P. Allison of the US and Tasuku Honio of Japan — who bagged the Nobel Prize in Physiology or Medicine for unleashing the...

Cancer researchers bag Nobel Prize; Fresenius wins case over terminating merger with Akorn due to data-integrity issues

04 Oct 2018

Radio Compass

PharmaCompass.com

FDA bans import of all APIs from Zhejiang Huahai; EU issues non-compliance certificate

In case you thought the US Food and Drug Administration (FDA) and EU’s actions against China’s Zhejiang Huahai Pharmaceutical (ZHP) for supplying commonly used blood pressure medicine valsartan with cancer-causi...

FDA bans import of all APIs from Zhejiang Huahai; EU issues non-compliance certificate

04 Oct 2018

Radio Compass

PharmaCompass.com

New Twists to Sartans Impurities Saga; Fish Oil Drug Makes Heart Medicine History

This week, Phispers brings you new twists to the valsartan impurities saga. First, the FDA posted its observations at Zhejiang Huahai Pharmaceuticals, post a recent inspection of its Linhai (China) site.  Second, the EMA sa...

New Twists to Sartans Impurities Saga; Fish Oil Drug Makes Heart Medicine History

27 Sep 2018

Radio Compass

PharmaCompass.com

Novartis seeks to clean image, links employee bonuses to ethics; EMA, FDA probe new impurity in valsartan

This week, Phispers brings you the latest on the valsartan contamination. FDA and EMA have found the presence of an additional unexpected impurity in valsartan drug products. We also bring you the string of measures being undertak...

Novartis seeks to clean image, links employee bonuses to ethics; EMA, FDA probe new impurity in valsartan

20 Sep 2018

Radio Compass

PharmaCompass.com

Top Pharma & Biotech Deals, Investments, M&As in August 2018

In August, the biotech boom of 2018 continued unabated and the Wall Street Journal reported that investment banks have lured top biotech analysts with guaranteed pay packages of US$ 3 million or more. At this time of the yea...

Top Pharma & Biotech Deals, Investments, M&As in August 2018

13 Sep 2018

Radio Compass

PharmaCompass.com

Sun, Dr. Reddy’s rework strategies to deal with US market; Novartis sells troubled US biz to Aurobindo

This week, Phispers has news on Indian generic drug makers. First, Sun Pharma and Dr. Reddy’s Laboratories announced their reworked strategies that are driven by severe pressures in the US market. While DRL plans to double i...

Sun, Dr. Reddy’s rework strategies to deal with US market; Novartis sells troubled US biz to Aurobindo

13 Sep 2018

Radio Compass

PharmaCompass.com

PharmaCompass